Molecular genetics of apolipoproteins and coronary heart disease.
A variety of DNA markers for apolipoprotein genes were examined among patients with angiocardiographically proven heart disease and among a variety of normal individuals with various lipid values. An increased frequency of an apoAI-CIII SstI RFLP and an apoB minisatellite (allele 5) was found among patients with CHD. Higher levels of cholesterol were found among carriers of the rare apoB TaqI and the common apoCII TaqI variants, whereas higher levels of triglycerides were found in carriers of the common apoAII MspI and the rare apoB XbaI variants. Lower levels of HDL were found among carriers of the common apoAII MspI and the rare apoB PvuII variants. The biological significance of these results and those of other investigators for the pathogenesis of CHD and hyperlipidemia is suggestive but not yet fully clarified. Additional genetic epidemiologic studies and family investigations will be required. Currently used statistical methodology may lead to false inferences regarding the genetic equilibrium or disequilibrium status of closely linked DNA variants. Conclusions regarding the presence of genetic equilibrium if closely linked flanking markers are in disequilibrium may be faulty.
D000483:Alleles; D001053:Apolipoproteins / Q000097:blood / Q000235:genetics*; D003324:Coronary Artery Disease / Q000097:blood / Q000235:genetics*; D003327:Coronary Disease / Q000209:etiology / Q000235:genetics; D004247:DNA / Q000378:metabolism; D005796:Genes; D006801:Humans; D006949:Hyperlipidemias / Q000235:genetics; D008297:Male; D012150:Polymorphism, Restriction Fragment Length; D012016:Reference Values
D001053:Apolipoproteins; D004247:DNA